Sun Nuclear, a wholly owned subsidiary of Mirion Technologies, Inc. (“Mirion”), today announced that it is developing new Quality Management solutions, in collaboration with Accuray, for the company’s Radixact® System with Synchrony®, which enables real-time, personalized adaptive radiation therapy. Initial innovations from the collaboration will be featured in the Sun Nuclear booth (980) at the ASTRO Annual Meeting, October 23-25, 2022, in San Antonio, Texas. The Enhanced Dynamic Platform, the first release to come from the expanded partnership, is a next-generation design of the Dynamic Platform from CIRS, now part of Sun Nuclear. It enables movement of compatible phantoms with sub-millimeter accuracy and reproducibility, easing quality assurance (QA) and boosting clinical confidence for advanced tumor treatments. The Enhanced Dynamic Platform allows for precisely controlled inferior-superior motion and features the ability to create an inclined plane for compatible phantom motion in the posterior-anterior direction. An independently controlled smaller platform provides surrogate chest wall motion. CIRS Motion Control Software enables different cycles, amplitudes, and waveforms – as well as the import of patient-specific respiratory waveforms.
Read more on that news here.